Baker McKenzie advised Sino Biopharmaceutical Limited on the deal. Sino Biopharmaceutical Limited signed a strategic partnership agreement with Boehringer Ingelheim to bring Boehringer Ingelheim’s innovative cancer therapies...
Sino Biopharmaceutical’s Partnership with Boehringer Ingelheim
Tubulis GmbH’s Series B2 Financing
Baker McKenzie advised EQT Life Sciences on the deal. EQT Life Sciences successfully closed a EUR 128 million (USD 138.8 million) Series B2 financing of Tubulis GmbH....
Sumitomo Rubber Industries’ Share Transfer of Lonstroff AG
Baker McKenzie advised Sumitomo Rubber Industries, Ltd. on the deal. Sumitomo Rubber Industries concluded an agreement to assign all shares it holds in Lonstroff AG to...
Seamless Therapeutics’ $12.5 Million Financing and In-Licensing
Baker McKenzie advised Seamless Therapeutics GmbH on the deal. Seamless Therapeutics GmbH executed the closing of a $12.5 million Seed Financing, a university carve-out including equity...
CTS Corporation’s Acquisition of Maglab AG
Baker McKenzie advised CTS Corporation on the deal. CTS Corporation executed the acquisition of Swiss-based maglab AG, a company with expertise in magnetic system design, primarily focused on...
mobilezone Group’s Acquisition of Digital Republic AG
Baker McKenzie advised the founders and owners of Digital Republic AG on the deal. Digital Republic AG (Digital Republic) sold the company to mobilezone Group (mobilezone)....
Tandem Diabetes Care’s Acquisition of AMF Medical
Homburger advised AMF Medical and its shareholders on the deal, while Baker McKenzie Switzerland advised Tandem Diabetes Care. Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global...
Lagardère Travel Retail’s Acquisition of Marché International AG
Baker McKenzie advised Mövenpick Group in the deal, while Willkie and Bär & Karrer advised Lagardère Travel Retail. Mövenpick Group sold the multi-brand international catering company Marché...
Datwyler’s Acquisition of CTsystems AG
Baker McKenzie Switzerland advised Datwyler on the transaction. Wenger Vieli advised the shareholders of CTsystems. Datwyler executed the acquisition of Swiss startup company CTsystems AG. Datwyler...
Tubulis’ €60 Million Series B Financing Round
CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
Allecra Therapeutics’ Licensing Agreement with Advanz Pharma
Baker McKenzie advised Allecra Therapeutics on the deal. Allecra Therapeutics signed an exclusive licensing agreement with Advanz Pharma Corp. Limited, a specialty pharmaceutical company with a strategic...
Merck’s Acquisition of Chord Therapeutics
Walder Wyss advised Merck on the deal, and Baker Mckenzie advised Chord Therapeutics SA. Merck entered into an agreement to acquire Chord Therapeutics SA, a Swiss-based...